Successful treatment by all-trans retinoic acid in a patient with acute promyelocytic leukemia complicated by liver cirrhosis and polycystic kidney

Internal Medicine

Volumn 48, Issue 18, 2009, Pages 1691-1694

  Yamane, Arito ^a   Tsukamoto, Norifumi ^a   Saitoh, Takayuki ^a   Uchiumi, Hideki ^a   Handa, Hiroshi ^c   Karasawa, Masamitsu ^b   Nojima, Yoshihisa ^a   Murakami, Hirokazu ^c  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY HOSPITAL   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Acute promyelocytic leukemia; All trans retinoic acid; Hypercalcemia; Liver cirrhosis; Renal failure

Indexed keywords

RETINOIC ACID;

ADULT; ARTICLE; CASE REPORT; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY POLYCYSTIC DISEASE; LEUKOCYTE COUNT; LIVER CIRRHOSIS; MALE; PANCYTOPENIA; PHYSICAL EXAMINATION; PROMYELOCYTIC LEUKEMIA; PROTHROMBIN TIME; THROMBOCYTE COUNT;

ANTINEOPLASTIC AGENTS; HUMANS; HYPERCALCEMIA; KIDNEY FAILURE, CHRONIC; LEUKEMIA, PROMYELOCYTIC, ACUTE; LIVER CIRRHOSIS; LIVER FAILURE; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY DISEASES; REMISSION INDUCTION; TRETINOIN;

EID: 70349484254     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2358     Document Type: Article

References (17)

1. Ohno R, Asou N, Ohnishi K. Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate. Leukemia 17: 1454-1463, 2003.
2. Chomienne C, Ballerini P, Balitrand N, et al. All-trans retinoic acid in acute promyelocytic leukemias. II In vitro studies: structure-function relationship. Blood 76: 1710-1717, 1990.
3. Rajpurkar M, Alcasabas P, Warrier I, et al. Effect of dialysis on all-trans retinoic acid levels in a child with acute promyelocytic leukemia and renal failure. Pediatr Blood Cancer 49: 994-996, 2007.
4. Takitani K, Nagai K, Kanbe E, et al. Pharmacokinetics of all-trans retinoic acid in acute prolmyelocytic leukemia patients on dialysis. Am J Hematol 74: 147-148, 2003.
5. Muindi JRF, Frankel SR, Huselton C, et al. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 52: 2138-2142, 1992.
6. Takatani K, Tamai H, Morinobu T, et al. 4-Oxo retinoic acid for refractory acute promyelocytic leukemia in children with all-trans retinoic acid therapy. J Nutr Sci Vitaminol 41: 493-498, 1995.
7. Muindi JRF, Young CW, Warrell RP Jr. Clinical pharmacology of all- trans retinoic acid. Leukemia 8: 1807-1812, 1994.
8. Farrington K, Miller P, Varghese Z, Baillod RA, Moorhead JF. Vitamin A toxicity and hypercalcaemia in chronic renal failure. Br Med J 282: 1999-2002, 1981.
9. Fishbane S, Frei GL, Finger M, Dressler R, Silbiger S. Hypervitaminosis A in two hemodialysis patients. Am J Kid Dis 25: 346-349, 1995.
10. De Botton S, Dombret H, Sanz M, et al: the European APL Group: Incidence, clinical features, and outcome of all-trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. Blood 92: 2712-2718, 1998.
11. Hisamori S, Tabata C, Kadokawa Y, et al. All-trans-retinoic acid ameliorates carbon tetrachloride-induced liver fibrosis in mice through modulating cytokine production. Liver Int 28: 1217-1225, 2008.
12. Wang L, Potter JJ, Rennie-Tankersley L, Novitskiy G, Sipes J, Mezey E. Effects of retinoic acid on the development of liver fibrosis produced by carbon tetrachloride in mice. Biochem Biophys Acta 1772: 66-71, 2007.
13. Akiyama H, Nakamura N, Nagasawa S, Sakamaki H, Onozawa Y. Hypercalcaemia due to all-trans retinoic acid. Lancet 339: 308-309, 1992.
14. Hatake K, Uwai M, Ohtsuki T, et al. Rare but important adverse effects of all-trans retinoic acid in acute promyelocytic leukemia and their management. Int J Hematol 66: 13-19, 1997.
15. Clines GA, Guise TA. Hypercalcemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr Relat Cancer 12: 549-583, 2005.
16. Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphophonates. Ann Oncol 17: 897-907, 2006.
17. 2/day. Eur J Haematol 55: 275-276, 1995.